Long-term drug use and polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina
Abstract
Background/Aim. Prescription of drugs is a fundamental care component of the elderly. Elderly patients often take multiple drugs, and it is known that polypharmacy may lead to drug interactions and adverse events. The aim of this study was to analyze the long-term drug use and the prevalence of polypharmacy among the elderly population in the Republic of Srpska, Bosnia and Herzegovina. Methods. A retrospective study of outpatient drug use in 2005 and 2010 was conducted, analyzing prescriptions for patients aged ≥ 65 years reimbursed by the Health Insurance Fund. The study population was stratified by gender and age. Long-term drug use was defined as continuous drug dispensing for a whole year or at least two thirds of the year. Polypharmacy was defined as the use of 5 or more different reimbursed drugs. Results. Of all insured people aged ≥ 65 years, long-term drug use was identified in 10% (2005) and in 19% (2010), of whom 62% were women. Two to four different drugs were used by almost 49% (2005) and 54% (2010) of the elderly patients. The polypharmacy prevalence increased from 1.4% (2005) to 3.6% (2010); it increased in all the age groups of both genders. The largest increase was observed in the age group 65–74 years. Polypharmacy prevalence increase was higher in women. The most commonly used drugs were those for to treatment of cardiovascular diseases, in particular drugs for hypertension and cardiac treatment. Conclusion. The study findings point out to the increase of elderly population with a long-term drug use. Over a half of elderly patients use 2–4 different drugs on the long-term basis. The polypharmacy prevalence was low. It increased in the period of 5 years in both genders. The increase was more prominent in women of all the age groups. The use of multiple drugs and polypharmacy increased with ageing.
References
Nobili A, Franchi C, Pasina L, Tettamanti M, Baviera M, Monesi L, et al. Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM-elderly project. Pharmacoepidemiol Drug Saf 2011; 20(5): 488−96.
Jyrkkä J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study. Eur J Clin Pharmacol 2006; 62(2): 151−8.
Slabaugh LS, Maio V, Templin M, Abouzaid S. Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy. Drugs Aging 2010; 27(12): 1019−28.
Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract 2007; 24(1): 14−9.
Holbeach E, Yates P. Prescribing in the elderly. Aust Fam Physi-cian 2010; 39(10): 728−33.
Venturini CD, Engroff P, Ely LS, Zago LF, Schroeter G, Gomes I, et al. Gender differences, polypharmacy, and potential pharmacological interactions in the elderly. Clinics (Sao Paulo) 2011; 66(11): 1867−72.
Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivelä S, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002; 55(8): 809−17.
Markovic-Pekovic V, Skrbić R, Godman B, Gustafsson LL. Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions. Expert Rev Pharmacoecon Outcomes Res 2012; 12(5): 661−71.
Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM. The develop-ment of polypharmacy. A longitudinal study. Fam Pract 2000; 17(3): 261−7.
Haider SI, Johnell K, Weitoft GR, Thorslund M, Fastbom J. The Influence of Educational Level on Polypharmacy and Inappropriate Drug Use: A Register-Based Study of More Than 600,000 Older People. J Am Geriatr Soc 2009; 57(1): 62−9.
Hovstadius B, Hovstadius K, Astrand B, Petersson G. Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008. BMC Clin Pharmacol 2010; 10(1): 16.
Gazibara T, Nurkovic S, Kisic-Tepavcevic D, Kurtagic I, Kovacevic N, Gazibara T, et al. Pharmacotherapy and over-the-counter drug use among elderly in Belgrade, Serbia. Geriatr Nurs 2013; 34(6): 486−90.
Republika Srpska Institute of Statistics. Demographic statistics. Demographic statistics. Banja Luka: Republički zavod za statistiku; 2002. (Serbian)
Republika Srpska Institute of Statistics. Women and men in Republika Srpska. Banja Luka: Republički zavod za statistiku; 2012. (Serbian)
Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Pat-terns of Drug Use and Factors Associated with Polypharmacy and Excessive Polypharmacy in Elderly Persons. Drug Aging 2009; 26(6): 493−503.
Franchi C, Tettamanti M, Pasina L, Djignefa CD, Fortino I, Bortolotti A, et al. Changes in drug prescribing to Italian community-dwelling elderly people: the EPIFARM-Elderly Project 2000-2010. Eur J Clin Pharmacol 2014; 70(4): 437−43.
Nerat T, Kos M. Analysis of inappropriate medication prescrib-ing in Slovenian elderly patients based on the Beers and Laroche criteria. Zdrav Var 2011; 50(1): 34−44.
Juloski J, Despotović N, Vujisić A, Erceg P, Milosević DP, Marjanović S, et al. Nonsteroidal anti-inflammatory drugs: as inappropriate pharmacotherapy in the elderly. Adv Gerontol 2011; 24(2): 308−11.
Popović B, Quadranti-Radošević N, Matanović-Mimica S, Lisica-Diminić I, Ljubotina A, Duliba-Pezelj D, et al. Potentially inappropriate prescribing in elderly outpatients in Croatia. Eur J Clin Pharmacol 2014; 70(6): 737−44.
Rolevski M, Kučević B, Boljević G, Mugoša S, Mikov M. Potentially inappropriate medication use in the elderly in Montenegro. BMC Pharmacol Toxicol 2012; 13(Suppl 1): A35.
Bjerrum L, Søgaard J, Hallas J, Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol 1998; 54(3): 197−202.
Rozenfeld S, Fonseca MJ, Acurcio FA. Drug utilization and polypharmacy among the elderly: a survey in Rio de Janeiro City, Brazil. Rev Panam Salud Publica 2008; 23(1): 34−43.
Chan DD, Hao Y, Wu S. Polypharmacy among disabled Taiwanese elderly: a longitudinal observational study. Drugs Aging 2009; 26(4): 345−54.
Chrischilles EA, Foley DJ, Wallace RB, Lemke JH, Semla TP, Hanlon JT, et al. Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol 1992; 47(5): 137−44.
Kennerfalk A, Ruigómez A, Wallander M, Wilhelmsen L, Johansson S. Geriatric drug therapy and healthcare utilization in the United kingdom. Ann Pharmacother 2002; 36(5): 797−803.
Ribeiro AQ, Rozenfeld S, Klein CH, César CC, de Acurcio FA. Survey on medicine use by elderly retirees in Belo Horizonte, South-eastern Brazil. Rev Saude Publica 2008; 42(4): 724−32.
Markovic-Pekovic V, Stoisavljevic-Satara S, Skrbic R. Utilisation of cardiovascular medicines in Republic of Srpska, Bosnia and Herzegovina, 5 years study. Pharmacoepidemiol Drug Saf 2009; 18(4): 320−6.
Ministry of Health and Social Welfare of the Republic of Srpska. Guidelines for Clinical Practice. Guidelines for Clinical Practice. Cardiovascular diseases: Hypertension/Atrial fibrila-tion/Myocardial infarction/Angina pectoris. Banja Luka: Ministry of Health and Social Welfare of the Republic of Srpska; 2004. (Serbian)
Lionakis N, Mendrinos D, Sanidas E, Favatas G, Georgopoulou M. Hypertension in the elderly. World J Cardiol 2012; 4(5): 135−47.
Dickerson LM, Gibson MV. Management of hypertension in older persons. Am Fam Physician 2005; 71(3): 469−76.
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31(7): 1281−57.
Ministry of Health and Social Welfare of the Republic of Srpska. Guideline for Diabetes mellitus. Banja Luka: Ministry of Health and Social Welfare of the Republic of Srpska; 2004. (Serbian)